\n<\/p>\n
Save for about a couple of minutes a little before noon, the Switzerland stock market languished in negative territory on Friday. <\/p>\n
However, with selling interest remaining subdued, the downside was not much and the market ended the session just marginally down.<\/p>\n
The benchmark SMI ended lower by 6.39 points or 0.06% at 10,967.37, after scaling a low of 10,891.67 and a high of 10,975.90 in the session.<\/p>\n
Richemont ended lower by about 3%. Swatch Group, UBS Group, Sika and Credit Suisse shed 1.3 to 1.75%. SGS and Swiss Life Holding both ended lower by about 1%, while Alcon, LafargeHolcim, Zurich Insurance Group and Partners Group lost 0.6 to 0.85%.<\/p>\n
Nestle advanced 1.2%, ABB gained 0.9%, Novartis moved up by about 0.4% and Roche Holding gained 0.6%. Roche’s subsidiary Genentech is recalling prescription drug Evrysdi or risdiplam as it failed to meet child resistant packaging requirements, according to the U.S. Consumer Product Safety Commission.<\/p>\n
In the midcap section, Georg Fischer declined 2.8%. Clariant and Flughafen Zurich both closed lower by about 2.2%, while OC Oerlikon Corp, Sonova, Adecco, AMS, Baloise Holding and Straumann Holding lost 1.2 to 1.6%.<\/p>\n
SIG Combibloc moved up 3.1%, PSP Swiss Property, Temenos Group, Vifor Pharma and Swiss Prime Site gained 1.2 to 2%, and Tecan Group ended 1.1% up. <\/p>\n<\/p>\n<\/div>\n